CurrentBody Series 2 at a Glance: Key Upgrades, Specifications, and What Changed

At MICEYLIVE, we help you understand face and body light-care formats before choosing a device.

The CurrentBody Skin LED Light Therapy Face Mask Series 2 represents a major architectural redesign of the brand's category-defining beauty device. Most notably, CurrentBody has expanded the LED count from 132 diodes in Series 1 to 236 precision bulbs in Series 2—an increase of 78.8%—while introducing a third therapeutic wavelength at 1072 nm deep near-infrared. Additionally, the chassis integrates a submental chin strap alongside an updated liquid silicone mold to secure flush skin contact, priced at $469.99 compared to the original model's $380.00 retail tag.

For prospective buyers evaluating the at-home phototherapy market, the central question is whether these physical and optical modifications justify an $89 price increase over the original model and benchmark alternatives like Omnilux Contour. While marketing campaigns often emphasize higher diode counts, therapeutic cellular stimulation is governed by strict photobiological parameters: optical coupling, wavelength precision, and calibrated power density. In direct benchmark evaluation, Series 2 features 236 LEDs and 3 wavelengths (633/830/1072nm) with an integrated chin strap, compared to Omnilux Contour (132 LEDs, 633/830nm, dual strap at $395) and Series 1 (132 LEDs, 633/830nm, single strap at $380).

The Photophysics of 1072 nm Deep Near-Infrared: How the Third Wavelength Functions

Photobiomodulation in human skin operates through cellular chromophore absorption. For superficial and mid-dermal tissue remodeling, standard clinical phototherapy delivers 633 nm red light and 830 nm near-infrared light. These wavelengths are absorbed by cytochrome c oxidase, a crucial terminal enzyme in the mitochondrial electron transport chain, stimulating adenosine triphosphate (ATP) synthesis, enhancing fibroblast activity, and accelerating procollagen production. Red light at 633 nm penetrates 1 to 2 mm into the papillary dermis, while 830 nm near-infrared reaches 2 to 3 mm into the reticular dermis to improve microvascular circulation and cellular repair.

The primary scientific upgrade in CurrentBody Series 2 is the addition of 1072 nm deep near-infrared light, strategically positioned over the perioral and under-eye zones. In the optical spectrum between 1000 nm and 1100 nm, cutaneous scattering coefficients drop markedly, and optical absorption by both melanin and water reaches a localized minimum. This optical transmission window allows 1072 nm photons to penetrate 3 to 5 mm into the deep reticular dermis and upper subcutaneous tissue layers. At this depth, photons bio-stimulate deep extracellular matrix fibroblasts and structural anchor collagen without inducing bulk photothermal tissue heating, offering targeted therapy for deeper perioral creases and nasolabial folds.

Optical Metrology & Dosing: Irradiance, Fluence, and Pillow Technology Diffusion

Evaluating an LED mask requires auditing its optical power delivery rather than its raw diode count. The CurrentBody Series 2 operates at an irradiance of approximately 30 mW/cm². Photobiological dosing is calculated using the standard formula: Fluence (J/cm²) = Irradiance (W/cm²) × Time (seconds). Over its automated 10-minute (600 seconds) operating cycle, 30 mW/cm² yields an unattenuated surface energy dose of roughly 18 J/cm². Under the Arndt-Schulz biphasic dose law, low-to-moderate fluence stimulates cellular respiration, whereas excessive energy delivery (>50 J/cm²) induces cellular photoinhibition. To ensure even distribution across curved facial topographies, CurrentBody integrates Pillow Technology—specialized micro-lenses embedded above each LED cluster that disperse light beams broadly to eliminate hotspots. Accounting for natural surface reflection, tissue absorption scattering, and optical diffusion, the effective delivered tissue fluence settles within the verified clinical therapeutic window of 6 to 12 J/cm², delivering consistent bio-stimulation without localized hot spots.

Fit, Ergonomics & Optical Coupling: How the Submental Chin Strap Eliminates Photon Loss

In non-coherent LED phototherapy, the physical interface between the device and skin directly governs clinical efficacy through the inverse-square law. Optical physics dictates that radiant energy falls off rapidly with distance (E = P / 4πr²). In rigid polycarbonate plastic helmets, the static shell cannot conform to varying jawline angles, introducing a 1 to 3 cm air gap between the LEDs and the lower face. This air gap causes 50% to 80% of emitted photons to scatter, reflect, or disperse before penetrating the stratum corneum. CurrentBody Series 2 resolves this mechanical challenge by upgrading its flexible medical-grade liquid silicone architecture with an integrated submental chin strap. The dual-strap harness anchors the upper face, while the chin strap pulls the lower perimeter flush against the submental contour and jawline. This zero-gap optical coupling eliminates air scattering, ensures perpendicular photon entry, and delivers the full intended irradiance to the lower third of the face—an anatomical zone that frequently experiences the earliest signs of structural skin laxity.

Clinical Rejuvenation Evidence: What Peer-Reviewed Dermatological Trials Reveal

The therapeutic claims surrounding red and near-infrared light are substantiated by extensive peer-reviewed clinical research and systematic dermatology reviews. In randomized controlled trials investigating 633 nm and 830 nm light delivery, subjects undergoing consistent treatment demonstrated statistically significant reductions in periorbital fine lines, wrinkle depth, and skin roughness. High-frequency intradermal ultrasonography confirmed measurable increases in collagen density within the reticular dermis, validating that light therapy triggers genuine structural extracellular matrix remodeling rather than superficial, temporary skin plumping. A comprehensive systematic review published in the Journal of the American Academy of Dermatology (JAAD) analyzing 31 clinical trials on at-home LED devices corroborated these outcomes, reporting significant improvements in skin elasticity and firmness among compliant participants. Furthermore, clinical profilometry confirms that combined red and near-infrared light stimulates superficial papillary fibroblasts and deep microvascular perfusion synergistically over an 8-to-12-week timeframe.

When investing in at-home phototherapy, regulatory verification is essential. The CurrentBody Skin LED Mask Series 2 holds FDA 510(k) Class II Over-the-Counter clearance under 21 CFR 878.4810 (K240685), establishing that the device is substantially equivalent in safety, thermal output, and optical radiation to clinical predicate devices for wrinkle reduction. Crucially, FDA 510(k) clearance signifies verified hardware safety and manufacturing compliance; it should not be confused with pharmaceutical premarket approval (PMA).

Ocular safety is certified under IEC 62471 photobiological standards, confirming that non-coherent optical emissions pose minimal retinal hazard, though users should utilize the included opaque silicone eye inserts during treatment to prevent glare sensitivity and retinal strain.

Clinical protocol consistency is the single largest determinant of user success. Dermatologists recommend using the Series 2 three to five times weekly for 10 minutes per session on clean, dry skin. Applying thick creams or photosensitive serums prior to illumination should be avoided, as heavy lipids can reflect incoming light beams. Consistent compliance across an 8-to-12-week protocol is necessary to achieve structural collagen matrix reorganization.

While non-invasive photobiomodulation produces negligible thermal heating, treatment is strictly contraindicated for individuals with active light-sensitive epilepsy, cutaneous lupus erythematosus, or those taking photosensitizing medications such as systemic isotretinoin or tetracycline antibiotics.

Buyer Verdict & Upgrade Decision Matrix: Who Should Buy Series 2 vs Series 1?

At $469.99, CurrentBody Series 2 sits at the upper tier of the consumer LED face mask market. Compared head-to-head with the original Series 1 ($380.00, 132 LEDs, 633/830 nm) and Omnilux Contour ($395.00, 132 LEDs, 633/830 nm), Series 2 delivers tangible hardware advancements: 78.8% more LED bulbs, an innovative 1072 nm deep near-infrared wavelength, and an integrated submental chin strap.

For first-time buyers seeking the most advanced optical coverage and targeted jawline treatment, Series 2 represents a justifiable premium investment. However, for existing Series 1 owners whose primary cosmetic goal is maintaining general collagen production and superficial tone, upgrading is not an urgent necessity. The original CurrentBody mask and Omnilux Contour continue to provide the clinically proven 633 nm and 830 nm wavelengths that drive the majority of mitochondrial ATP stimulation. Upgrading to Series 2 is primarily recommended for individuals specifically targeting persistent nasolabial folds, perioral wrinkles, or lower facial laxity who can benefit directly from the deeper 1072 nm penetration and zero-gap chin strap coupling.

For the next step, read our guide to Best LED Face Masks: Buying Guide and Honest Brand Reviews.